Email

Stover, Kathy (NIH/NIAID) [E] mail.nih.gov> niaid.nih.gov>; Chan, Alan (NIH/VRC) [E] I mail.nih.gov>; nih.gov>; Koup, Richard (NIH/VRC) [E] gov>; Graham, Barney (NIH/VRC) [E] mail.nih.gov>; Kelley, Ken (NIH/NIAID) [C] Mittelman, Abraham (NIH/VRC) [C] mail.nih.gov>; Kwong, Peter (NIH/VRC) [E] Subject: Re: JOHN: June NIH/BMGF meeting nih.gov>; mail.nih.gov> Sounds good to me. I'll mention to Tony and see if he wants to preface the overview. Pretty sure he will want to - you two have done that drill before. I'll be back in touch. Thanks! On May 11, 2017, at 8:37 PM, Mascola, John (NIH/VRC) [E] HR oil nih. gov> wrote: Hi Courtney, Thanks for the update. We will hold the 1-2pm timeframe on June gn. and Marybeth can be POC for coordinating logistics. I don't think Bill knows much about VRC; i.e. our portfolio of diseases, technologies, capabilities, pilot plan etc, so I think it would be useful for me to give a 15 min overview. Tony can decide if he wants to preface that. While tours are great -- at the end of the day, a lab is a lab, so I favor Given that a hour often ends up being 50 min, I'd propose 15 min overview and 5 min questions and 30 min tour. For tour -- given BMGF request to focus on structure-based vaccine design, that should be one key element Tour hat /vRc) (E] I > is afternoon and said that Gates would like iid work for you all? They are suggesting ring Right now it still /vRc) (E] __ > Structure based vaccine design - Suggest we highlight how concepts and lessons from structure-based vaccine design from HIV and RSV are informing vaccine design of additional diseases such as Flu, PIV, MERS and related CoV. Would suggest that Barney and Peter could tag team this. Above may be all we can fit for an hour tour. If we want another topic, we can discuss if Malaria or other, but that may be too ambitious. Lest us know what you think, Best, John